Forian Inc. (NASDAQ:FORA - Get Free Report) shares fell 2% during mid-day trading on Monday . The company traded as low as $1.99 and last traded at $2.00. 10,769 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 16,409 shares. The stock had previously closed at $2.04.
Analyst Ratings Changes
Separately, Roth Mkm reiterated a "buy" rating and issued a $5.00 price objective on shares of Forian in a research report on Thursday, November 14th.
View Our Latest Stock Analysis on Forian
Forian Price Performance
The stock's fifty day simple moving average is $2.07 and its 200-day simple moving average is $2.33. The company has a market capitalization of $63.27 million, a P/E ratio of -22.67 and a beta of 1.07.
Hedge Funds Weigh In On Forian
An institutional investor recently bought a new position in Forian stock. Caprock Group LLC purchased a new position in shares of Forian Inc. (NASDAQ:FORA - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 86,784 shares of the company's stock, valued at approximately $230,000. Caprock Group LLC owned approximately 0.28% of Forian as of its most recent filing with the SEC. Institutional investors and hedge funds own 19.25% of the company's stock.
About Forian
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Recommended Stories
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
